This page was machine-translated from Korean. For medical decisions, please confirm with the hospital.View in Korean

Conditions treated

  • Myelodysplastic syndrome
  • Hematopoietic stem cell transplantation
  • Leukemia
  • Lymphoma
  • Multiple myeloma
  • Anemia/Platelet disorders
  • Myeloproliferative neoplasms
  • Blood coagulation disorders/Bleeding disorders

Professor Kim Byeong-su has gained patients’ trust through attentive care and detailed explanations, specializing in myelodysplastic syndromes and bone marrow transplantation.

Hospital information

Hospital
Korea University Anam Hospital
Address
73 Inchon-ro, Seongbuk-gu, SeoulOpen in Google Maps
Appointments
1577-0083

Education

  • 2000–2002 Korea University Graduate School of Public Health, Master of Public Health (specialization: health policy and hospital management)
  • 1990–1996 Korea University Graduate School, Doctor of Medicine (specialization: hematology and oncology)
  • 1988–1990 Korea University Graduate School, Master of Medicine (specialization: internal medicine)
  • 1981–1987 Korea University, Bachelor of Medicine

Career

  • 2012– Head of the Translational Research Group, R&D Promotion Division, Korea Health Industry Development Institute
  • 2012– Board Member, Korean Society for Stem Cell Research
  • 2012– Chair, Education and Training Committee, Korea University Anam Hospital
  • 2011– Head of the On-Site Evaluation Team, Evaluation and Accreditation Team, Korea Institute for Healthcare Accreditation
  • 2011–2012 Member, PM Operations Committee, R&D Promotion Division, Korea Health Industry Development Institute
  • 2011– Head of Education and Training / Head of the QA Office, Clinical Trial Center, Korea University Anam Hospital
  • 2011– Member, Textbook Compilation Committee, Korean Society of Hematology
  • 2010– Member, Committee for Improving the Pharmacy System, Ministry of Education, Science and Technology
  • 2010– Council Member, Korean Association of Internal Medicine
  • 2010–2011 Member of the CEO Evaluation Group (2010), Deputy Head (2011), Gyeonggi Research Institute
  • 2009– Chair, Institutional Review Board, Korea University Anam Hospital
  • 2009– Director, Korea University Stem Cell Research Institute
  • 2009–2009 Evaluator, Medical School Evaluation Group, Korean Institute of Medical Education and Evaluation
  • 2009– Member, Stem Cell Line Registration Committee, Korea Centers for Disease Control and Prevention
  • 2009– Chair of the On-Site Evaluation Team, Evaluation Bureau, Korean Association of Institutional Review Boards
  • 2009–2010 Member, Committee for Improving the Dental and Medical Education Systems, Ministry of Education, Science and Technology
  • 2009–2011 Head of Clinical Trials, Clinical Trial Center, Korea University Anam Hospital
  • 2008– Member, Expert Committee for Evaluating Bioethics Education, Ministry of Health and Welfare
  • 2008–2011 Director, Center for Teaching and Learning Support, Korea University College of Medicine
  • 2008– Member, Professional Committee, Korean Association of Medical Colleges and Graduate Medical Schools (KAMC)
  • 2007– Head, Division of Hematology and Oncology, Korea University Anam Hospital
  • 2007–2011 Vice Dean for Education, Korea University College of Medicine
  • 2007–2010 Vice Dean for Medical Affairs, Korea University Graduate School
  • 2007–2007 Western IRB Trainee
  • 2007– Council Member, Korean Society of Hematology
  • 2007–2011 Chair, Department of Medical Education, Korea University College of Medicine
  • 2007– Council Member, Korean Society for Blood and Marrow Transplantation
  • 2007–2007 Head, JCI Accreditation Task Force Team, Korea University Anam Hospital
  • 2006–2007 Visiting Scholar, Malcolm AS Moore’s Laboratory, Memorial Sloan Kettering Cancer Center
  • 2006– Member, Institutional Review Board, Korea University
  • 2005–2006 Board Member Without Portfolio, Korean Society of Hematology
  • 2004–2005 Head, Cost Accounting Development Task Force, Korea University Medical Center
  • 2003–2005 Chair, Appropriate Care Management Committee, Korea University Anam Hospital
  • 2002–2003 Member, Consultative Committee for Reviewing Good Tissue Practice Standards, Korea Food and Drug Administration
  • 2000– Member, Transplant Coordination Committee, Korean Marrow Donor Program
  • 2012– Application for “Placenta-Derived Cell-Conditioned Culture Media and Animal-Free, Feeder-Free Method for Culturing Stem Cells Using the Same” (United States)
  • 2012– Patent decision for “Method for Culturing Human Embryonic Stem Cells Using Human Placenta-Derived Support Cells and Culture Medium Thereof” (Republic of Korea)
  • 2010– Registration of “Method for Inducing and Culturing the Differentiation of Human Bone Marrow and Umbilical Cord Blood Mononuclear Cells into CD34+ Hematopoietic Stem Cells or CD14+ Monocytes Using Human Placenta-Derived Mesenchymal Stem Cells” (Republic of Korea)
  • 2006– Registration of “Adenovirus Producing Antisense Telomerase and Method for Inducing and Proliferating the Differentiation of Embryonic Stem Cells into Hematopoietic Stem Cells Using the Same” (Republic of Korea)
  • 2007– Registration of “Cost Management Method, Apparatus, and System for Hospital Groups and Individual Hospitals” (Republic of Korea)

Frequently asked questions

What conditions does Kim Byeong-su treat?
Kim Byeong-su treats Myelodysplastic syndrome, Hematopoietic stem cell transplantation, Leukemia, Lymphoma and Multiple myeloma.
Where does Kim Byeong-su see patients?
Kim Byeong-su sees patients in Hematology and Oncology at Korea University Anam Hospital. 73 Inchon-ro, Seongbuk-gu, Seoul
How do I book an appointment with Kim Byeong-su?
Book through the hospital website or by phone (1577-0083). Large university hospitals usually need a referral letter from a local clinic for National Health Insurance to apply.